125 related articles for article (PubMed ID: 1828404)
1. [Essential arterial hypertension and Leriche-Fontaine stage II obliterating vascular disease of the lower limbs. A new pharmacological approach with ketanserin].
Mollo P
Clin Ter; 1991 Apr; 137(2):113-5. PubMed ID: 1828404
[TBL] [Abstract][Full Text] [Related]
2. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
[TBL] [Abstract][Full Text] [Related]
3. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
[TBL] [Abstract][Full Text] [Related]
6. [The clinical significance of serotonin antagonists].
Regenthal R; Voigt H
Z Gesamte Inn Med; 1989 Sep; 44(17):504-8. PubMed ID: 2686226
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
[TBL] [Abstract][Full Text] [Related]
8. [Role of ketanserin in the treatment of arterial hypertension].
Cricco L
Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
[TBL] [Abstract][Full Text] [Related]
9. Arteriosclerosis obliterans of the lower limbs as a model of peripheral vascular disease with hypertension.
Safar ME
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S73-7. PubMed ID: 1721984
[TBL] [Abstract][Full Text] [Related]
10. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
Andreozzi GM; Lepore R
Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
[TBL] [Abstract][Full Text] [Related]
11. [Ketanserin and metoprolol in the treatment of essential hypertension].
Cerasola G; Contorno A; D'Ignoto G; Talamo AR; Vallone A; Zilietti T
Clin Ter; 1990 Aug 15-31; 134(3-4):193-7. PubMed ID: 2147620
[TBL] [Abstract][Full Text] [Related]
12. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
Voigt H; Reuter W; Hofmann B; Dobberkau A
Z Gesamte Inn Med; 1990 May; 45(10):283-7. PubMed ID: 2392858
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-therapeutic experience with a new antihypertensive drug, ketanserin, in elderly patients].
Neri G; Iovine C
Clin Ter; 1989 Sep; 130(5):245-8. PubMed ID: 2530025
[TBL] [Abstract][Full Text] [Related]
14. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
15. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
[TBL] [Abstract][Full Text] [Related]
16. [Use of a new preparation of flunarizine in patients with peripheral obliterating arteriopathy at the second stage. Controlled clinical study].
Guerrini M; Pieragalli D; De Franco V; Di Perri T
Clin Ter; 1989 Jun; 129(6):445-58. PubMed ID: 2526706
[TBL] [Abstract][Full Text] [Related]
17. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
Novo S; Alaimo G; Giordano U; Raineri A; Strano A
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
[TBL] [Abstract][Full Text] [Related]
18. [Effects of treatment with ACE and serotonin inhibitors on arterial blood pressure at rest and cycloergometric exercise and on systolic time intervals: comparison of enalapril and ketanserin].
Cumetti CM; Brina A
Ann Ital Med Int; 1990; 5(4 Pt 2):503-23. PubMed ID: 2102138
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
[TBL] [Abstract][Full Text] [Related]
20. [Intra-arterial infusion in the treatment of severe forms of occlusive vascular diseases of the lower limbs].
Lytkin MI; Nazarov GD; Barinov VS
Vestn Khir Im I I Grek; 1981 Jan; 126(1):78-82. PubMed ID: 7222426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
